Atlas Trials

Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome

Clinical trial NCT06731192 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06731192
Sponsor
Guangzhou Women and Children's Medical Center
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Alport Syndrome
Start date
2025-01-01
Primary completion
2026-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.